📰 Topline Phase News
Page 2 - Topline Phase News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Topline Phase. Real-time updates on events, politics, business and more.
November 4, 2022
WALTHAM, Mass., Nov. 04, 2022 -- CinCor Pharma, Inc. is re-issuing its earnings press release for the third quarter ended September 30, 2022, issued on November 3, 2022 at 8:00 am ET, to correct... | November 4, 2022
August 8, 2022
Positive topline data in the Phase 2 BrigHtn trial, demonstrating clinically meaningful and statistically significant reduction in blood pressure with baxdrostat in treatment-resistant hypertension ... | August 8, 2022
February 17, 2022
Prothena Reports Fourth Quarter and Full Year 2021 Financial Results, and Provides Financial Guidance and Business Highlights •Net cash used in operating... | February 17, 2022
November 3, 2021
Therapies in the oncology, neurology and autoimmune disease pipelines could soon pose challenges to existing standards of care.
May 11, 2021
Goldman Sachs started coverage of Horizon Pharma PLC (NASDAQ: HZNP) with a Buy rating and $24 target price, implying 34 percent upside, on the strength of its emerging orphan franchise. Attractive Story "We view HZNP as an attractive SOTP story in transformation with management using the strong... Read More... Dont Miss Any Updates! News Directly in Your Inbox Subscribe to: